Quiz | Physician's Weekly
Advertisement

Quiz

PhysQuiz Answers! APA 2021: Tardive Dyskinesia

How did you do?   1) A post-hoc analysis of AIMS data from a long-term valbenazine study, KINECT 4 to assess the patterns of improvement of patients with TD found that what percentage of patients receiving valbenazine met...

PhysQuiz Answers! SABCS 2020

1) In an updated analysis of the phase 2 DESTINY-Breast01 study, women with HER2-positive metastatic breast cancer ADC trastuzumab deruxtecan (Enhertu) continued to demonstrate favorable data, including a median progression-free...

PhysQuiz Answers! AAN 2021: Multiple Sclerosis

Which of the following is a preliminary outcome of the retrospective, multi-center observational study in a cohort of Italian MS patients investigating the impact of disease-modifying treatments on COVID-19 course of disease?a)...

PhysQuiz Answers! A Focus on Allergic Asthma

Thank you for taking our quiz on allergic asthma! How did you do? 1) What percent of patients diagnosed with severe asthma (mean age of 12 years)  were drug adherent, according to a study presented at AAAAI? a) 43% b) 57% c) 68%...

PhysQuiz Answers! A Focus on Chronic Idiopathic Urticaria

Thank you for taking our quiz on chronic urticaria! How did you do? 1) The NCBI recently released recommendations for diagnosis and management of chronic idiopathic urticaria, recommends using a skin prick test as part of...

PhysQuiz Answers! ASCO GU: Renal Cell Carcinoma

1)  Results released from the Phase 3 CLEAR Trial found that lenvatinib combined with EITHER of these two drugs demonstrated significant benefits over sunitinib in patients with advanced RCC:   a) pembrolizumab or...

PhysQuiz Answers! ACR Convergence 2020

Thank you for taking our quiz on PsA from results presented at ACR Convergence 2020! How did you do? 1) DMARD-naïve patients achieving Routine Assessment of Patient Index Data 3 (RAPID3) and the Clinical Disease Activity for...

Loading

Advertisement

For latest news and updates
Email-id is invalid